Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease
Authors
Keywords
Blood plasma, Fibroblast growth factor, Glomerular filtration rate, Vitamin D, Phosphates, Prognosis, C-reactive proteins, Coronary heart disease
Journal
PLoS One
Volume 9, Issue 4, Pages e95402
Publisher
Public Library of Science (PLoS)
Online
2014-04-19
DOI
10.1371/journal.pone.0095402
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
- (2013) Benjamin D. Parker ANNALS OF INTERNAL MEDICINE
- The Effects of Low Vitamin D on Coronary Artery Disease
- (2013) Wei Ren Chen et al. Heart Lung and Circulation
- Vitamin D serum levels are associated with cardiovascular outcome in coronary artery disease
- (2013) Gerasimos Siasos et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
- (2013) Julia J. Scialla et al. KIDNEY INTERNATIONAL
- Associations of Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Concentrations With Death and Progression to Maintenance Dialysis in Patients With Advanced Kidney Disease
- (2012) Jessica Kendrick et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- 25-Hydroxyvitamin D Levels and Risk of Ischemic Heart Disease, Myocardial Infarction, and Early Death
- (2012) Peter Brøndum-Jacobsen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A preliminary study of the potential role of FGF-23 in coronary calcification in patients with suspected coronary artery disease
- (2012) Hirofumi Masai et al. ATHEROSCLEROSIS
- Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease
- (2012) Lu Wang et al.
- Combined Use of Vitamin D Status and FGF23 for Risk Stratification of Renal Outcome
- (2012) C. Nakano et al. Clinical Journal of the American Society of Nephrology
- Phosphate: a novel cardiovascular risk factor
- (2012) M. Ketteler et al. EUROPEAN HEART JOURNAL
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
- (2012) et al. EUROPEAN HEART JOURNAL
- Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease
- (2012) Ravi Thadhani et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Low Levels of Serum 25-Hydroxyvitamin D Are Associated with Increased Risk of Myocardial Infarction, Especially in Women: Results from the MONICA/KORA Augsburg Case-Cohort Study
- (2012) Mahir Karakas et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community
- (2012) Johan Ärnlöv et al. KIDNEY INTERNATIONAL
- Vitamin D receptor activation and cardiovascular disease
- (2012) E. Gonzalez-Parra et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease
- (2011) Eric N. Taylor et al. AMERICAN HEART JOURNAL
- Vitamin D and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
- (2011) Mohamed B. Elamin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Vitamin D and Cardiovascular Disease
- (2011) Carl J. Lavie et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cross Talk Between the Renin-Angiotensin-Aldosterone System and Vitamin D-FGF-23-klotho in Chronic Kidney Disease
- (2011) M. H. de Borst et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study
- (2011) Heart Protection Study Collaborative Group LANCET
- Autocrine/Paracrine Action of Vitamin D on FGF23 Expression in Cultured Rat Osteoblasts
- (2010) Wen-Jing Tang et al. CALCIFIED TISSUE INTERNATIONAL
- Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
- (2010) M. Wolf JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Vitamin D and cardiovascular disease: Systematic review and meta-analysis of prospective studies
- (2010) Norma C. Grandi et al. PREVENTIVE MEDICINE
- Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Relationship between circulating FGF23 and total body atherosclerosis in the community
- (2009) Majd A. I. Mirza et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Vitamin D and Sunlight: Strategies for Cancer Prevention and Other Health Benefits
- (2008) M. F. Holick Clinical Journal of the American Society of Nephrology
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started